Looking ahead to the second half of 2023, Samsung expects the overall smartphone market to return to year-on-year growth, particularly in the premium segment.
According to Meta, operating losses from the Reality Labs unit will “increase meaningfully year-over-year due to ongoing product development efforts in augmented reality/virtual reality and investments to further scale the ecosystem.”
Meta CEO Mark Zuckerberg highlighted that the company’s app continued to record strong engagement and currently has an exciting product in the pipeline.
The DIJA rally is going strong and withstanding pressure from sentiments surrounding the Fed’s increase in interest rates.
Sundar Pichai revealed that the company was planning to use new AI models to automate some customer services.
Stellantis reaffirmed its 2023 guidance and raised its growth outlook for Europe, the Middle East, and Africa from 5% to an impressive 7%.
The merger with Banc of California is adding to the general health of PacWest stock and will help the company avoid crashing.
The impressive revenue performance was largely driven by the Microsoft Cloud segment.
In addition to the better-than-expected Q2 2023 revenue, Alphabet did better than predicted in its ad profits.
General Motors reported strong financial results for Q2 2023, with a 52% increase in net earnings compared to the previous year. Despite potential labor stoppages, the company is optimistic about its future outlook.
Adidas is able to alleviate the impact of operational losses as the clearance of the massive Yeezy inventory takes turn for the good.
Apple noted that only account holders in the Apple Developer Program can apply for the Vision Pro kit, which should be returned upon request.
Moving on from the Q1 2024 result, Vodafone reiterated its guidance for fiscal 2024.
Phillips expressed concerns over the evolving relationships between major economic powers, such as the United States, China, and the European Union.
The pharmaceutical segment reported the highest sales with about $13.71 billion, followed by MedTech with a total sales of about $7.78 billion, and the remaining accrued from the consumer health segment.